Anterix Inc. (ATEX)
26.50 x 1 33.07 x 1
Post-market by (Cboe BZX)
30.83 -0.16 (-0.52%) 01/21/25 [NASDAQ]
26.50 x 1 33.07 x 1
Post-market 30.83 unch (unch) 16:01 ET
for Tue, Jan 21st, 2025
Fiscal Year End Date: 03/31
(Values in U.S. thousands)
09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
Sales | 1,551 | 1,525 | 1,260 | 1,271 | 1,052 |
Gross Profit | 1,551 | 1,525 | 1,260 | 1,271 | 1,052 |
Operating Expenses | 14,681 | 16,537 | 11,771 | 302 | -1,207 |
Operating Income | -13,130 | -15,012 | -10,511 | 969 | 2,259 |
Other Income | 594 | 710 | 970 | 697 | 459 |
Pre-tax Income | -12,536 | -14,302 | -9,541 | 1,666 | 2,718 |
Income Tax | 230 | 1,222 | -130 | 1,338 | 645 |
Net Income Continuous | -12,766 | -15,524 | -9,411 | 328 | 2,073 |
Net Income | $-12,766 | $-15,524 | $-9,411 | $328 | $2,073 |
EPS Basic Total Ops | -0.69 | -0.84 | -0.51 | 0.02 | 0.11 |
EPS Basic Continuous Ops | -0.69 | -0.84 | -0.50 | 0.02 | 0.11 |
EPS Diluted Total Ops | -0.69 | -0.84 | -0.51 | 0.02 | 0.11 |
EPS Diluted Continuous Ops | -0.69 | -0.84 | -0.50 | 0.02 | 0.11 |
EPS Diluted Before Non-Recurring Items | N/A | -0.84 | -0.51 | -0.55 | -0.55 |
EBITDA(a) | $-12,979 | $-14,833 | $-10,320 | $1,167 | $2,468 |